High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$979K
$979,789
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| APLS |
Apellis Pharmaceuticals, Inc.
|
CEO
Other
|
2026-02-03 | $33,238 | M | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-22 | $591,845 | S | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-20 | $161,946 | S | Form 4 |
| APLS |
Apellis Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-13 | $225,999 | S | Form 4 |